Associated Papers
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
40044654 (PubMed )
Supplement: 41397_2025_364_MOESM3_ESM.xlsx › Sheet1
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
Tate T et al.
Cancers, 2023
36831375 (PubMed )
Supplement: cancers-15-01031-s001.zip › Supplementary_Table_S1.xlsx › Table_S1
A novel class of somatic mutations in blood detected preferentially in CD8+ cells.
Valori M et al.
Clinical Immunology (orlando, Fla.), 2017
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.
Kalaora S et al.
Oncotarget, 2016
26819371 (PubMed )
Supplement: oncotarget-07-5110-s002.xlsx › Genome_sequencing
Clonal architectures and driver mutations in metastatic melanomas.
Ding L et al.
Plos One, 2014
25393105 (PubMed )
Supplement: pone.0111153.s002.zip › File_S2 › Table_S10.xls › Supp_Table_10
Select a paper to view details